SEC Form D · Amendment · filed September 25, 2020
Carmell Therapeutics Corp
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (21)
David W. Anderson · Pittsburgh, PADirectorJames J. Hart · Hershey, PAExecStephanie W. Kladakis · Pittsburgh, PAExecRichard Upton · Pittsburgh, PADirectorRandolph Hubbell · Pittsburgh, PAExec · DirectorDonna Godward · Pittsburgh, PAExecWendy W. Dicicco · Pittsburgh, PADirectorJames Connolly · Los Angeles, CAExec · DirectorJustin Fallon · Los Angeles, CADirectorJay Venkatesan · Los Angeles, CAExecEvan R. Kearns · Lexington, MADirectorChristian R. Cortis · Lexington, MAExecAlex R. Duncan · Lexington, MAExecFrances C. Hodler · CAMBRIDGE, MADirectorAndrew W. Dym · New York, NYExecJoseph W. Schottland · New York, NYDirectorMax Lin · MENLO PARK, CAExec · DirectorJim Momtazee · MENLO PARK, CAExecMark Bisso · HOUSTON, TXExecAndrew J. Duffy · New York, NYDirectorJefry A. Baker · Portland, ORDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗